These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 2785439)

  • 1. Accumulation of tetrahydrofolates in human plasma after leucovorin administration.
    Bunni MA; Rembiesa BM; Priest DG; Sahovic E; Stuart R
    Cancer Chemother Pharmacol; 1989; 23(6):353-7. PubMed ID: 2785439
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pharmacokinetics of leucovorin metabolites in human plasma as a function of dose administered orally and intravenously.
    Priest DG; Schmitz JC; Bunni MA; Stuart RK
    J Natl Cancer Inst; 1991 Dec; 83(24):1806-12. PubMed ID: 1744924
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Relationship between dose rate of [6RS]Leucovorin administration, plasma concentrations of reduced folates, and pools of 5,10-methylenetetrahydrofolates and tetrahydrofolates in human colon adenocarcinoma xenografts.
    Houghton JA; Williams LG; de Graaf SS; Cheshire PJ; Rodman JH; Maneval DC; Wainer IW; Jadaud P; Houghton PJ
    Cancer Res; 1990 Jun; 50(12):3493-502. PubMed ID: 2140289
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Plasma and tumor tissue pharmacology of high-dose intravenous leucovorin calcium in combination with fluorouracil in patients with advanced colorectal carcinoma.
    Trave F; Rustum YM; Petrelli NJ; Herrera L; Mittelman A; Frank C; Creaven PJ
    J Clin Oncol; 1988 Jul; 6(7):1184-91. PubMed ID: 3260621
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antitumour effects of pure diastereoisomers of 5-formyltetrahydrofolate in hepatic transplants of a rodent colon carcinoma model.
    Carlsson G; Gustavsson B; Frösing R; Odin E; Hafström LO; Spears CP; Larsson PA
    Biochem Pharmacol; 1995 Oct; 50(9):1347-51. PubMed ID: 7503782
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The effect of derivatives of folic acid on the fluorodeoxyuridylate-thymidylate synthetase covalent complex in human colon xenografts.
    Houghton JA; Schmidt C; Houghton PJ
    Eur J Cancer Clin Oncol; 1982 Apr; 18(4):347-54. PubMed ID: 6889511
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Influence of dose of [6RS]leucovorin on reduced folate pools and 5-fluorouracil-mediated thymidylate synthase inhibition in human colon adenocarcinoma xenografts.
    Houghton JA; Williams LG; Cheshire PJ; Wainer IW; Jadaud P; Houghton PJ
    Cancer Res; 1990 Jul; 50(13):3940-6. PubMed ID: 2354443
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Disposition of leucovorin and its metabolites in dietary folic acid-deplete mice - comparison between tumor, liver, and plasma.
    Raghunathan K; Schmitz JC; Priest DG
    Cancer Chemother Pharmacol; 1997; 40(2):126-30. PubMed ID: 9182833
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Relationship of reduced folate changes to inhibition of DNA synthesis induced by methotrexate in L1210 cells in vivo.
    Priest DG; Bunni M; Sirotnak FM
    Cancer Res; 1989 Aug; 49(15):4204-9. PubMed ID: 2743307
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Biochemical factors in the selectivity of leucovorin rescue: selective inhibition of leucovorin reactivation of dihydrofolate reductase and leucovorin utilization in purine and pyrimidine biosynthesis by methotrexate and dihydrofolate polyglutamates.
    Goldman ID; Matherly LH
    NCI Monogr; 1987; (5):17-26. PubMed ID: 2448654
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Chemical stability and human plasma pharmacokinetics of reduced folates.
    Odin E; Carlsson G; Frösing R; Gustavsson B; Spears CP; Larsson PA
    Cancer Invest; 1998; 16(7):447-55. PubMed ID: 9774951
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Disposition of leucovorin and its metabolites in the plasma, intestinal epithelium, and intraperitoneal L1210 cells of methotrexate-pretreated mice.
    Bunni MA; Sirotnak FM; Otter GM; Priest DG
    Cancer Chemother Pharmacol; 1994; 34(6):455-8. PubMed ID: 7923554
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Comparison between leucovorin and cisplatin as a modulator of 5-fluorouracil].
    Iba T; Yagi Y; Kidokoro A; Fukunaga T
    Gan To Kagaku Ryoho; 1993 Mar; 20(4):479-83. PubMed ID: 8452385
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Serum and cerebrospinal fluid distribution of 5-methyltetrahydrofolate after intravenous calcium leucovorin and intra-Ommaya methotrexate administration in patients with meningeal carcinomatosis.
    Mehta BM; Glass JP; Shapiro WR
    Cancer Res; 1983 Jan; 43(1):435-8. PubMed ID: 6600162
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Toxicity and antitumor activity of 5-fluorouracil in combination with leucovorin. Role of dose schedule and route of administration of leucovorin.
    Rustum YM
    Cancer; 1989 Mar; 63(6 Suppl):1013-7. PubMed ID: 2783877
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical pharmacology of the stereoisomers of leucovorin during repeated oral dosing.
    Schilsky RL; Choi KE; Vokes EE; Guaspari A; Guarnieri C; Whaling S; Liebner MA
    Cancer; 1989 Mar; 63(6 Suppl):1018-21. PubMed ID: 2783878
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Phase I study of phosphonacetyl-L-aspartate, 5-fluorouracil, and leucovorin in patients with advanced cancer.
    Hageboutros A; Rogatko A; Newman EM; McAleer C; Brennan J; LaCreta FP; Hudes GR; Ozols RF; O'Dwyer PJ
    Cancer Chemother Pharmacol; 1995; 35(3):205-12. PubMed ID: 7805178
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The metabolism of folinic acid (leucovorin) following oral and parenteral administration.
    Taguchi H
    J Nutr Sci Vitaminol (Tokyo); 1981; 27(4):283-90. PubMed ID: 6977022
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Combination of reduced folates with methotrexate or 5-fluorouracil. Comparison between 5-formyltetrahydrofolate (folinic acid) and 5-methyltetrahydrofolate in vitro activities.
    Etienne MC; Fischel JL; Formento P; Schneider M; Guillot T; Bardon M; Milano G
    Biochem Pharmacol; 1993 Nov; 46(10):1767-74. PubMed ID: 8250962
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Methylenetetrahydrofolate reductase polymorphism is associated with folate pool in gastrointestinal cancer tissue.
    Kawakami K; Omura K; Kanehira E; Watanabe G
    Anticancer Res; 2001; 21(1A):285-9. PubMed ID: 11299748
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.